adverse reaction reporting [Regulatives / Guidelines]

posted by drks  – 2006-12-08 17:16 (7124 d 11:31 ago) – Posting: # 387
Views: 7,817

Dear Pravin

❝ Give me a Idea About the serious advese event reporting form of formats


The reportings of SAEs are to be defined by proper SOPs developed in complinace with the GCP and applicable regulatory requirements (Schedule Y in your case...and mine too ;-) ).

The format defined by the schedule Y can be accessed here. Besides this, there will be some SOP driven forms, as well.

The formats shall include few necessary inputs viz.

"when, what and how" of the event occurred
outcome, if available
details of the study
management of the event

The timelines for the reporting of the SAE are to be strictly followed as per GCP. The authorities to be informed would normally include IRB, DCGI and pharmacovigilance division of your organisation.

i hope the query is answered to some extent. Any further inputs from other researchers would be appreciated.

regards,

Dr Kshitij Soni
Ranbaxy, India

Complete thread:

UA Flag
Activity
 Admin contact
23,653 posts in 4,991 threads, 1,570 registered users;
230 visitors (0 registered, 230 guests [including 52 identified bots]).
Forum time: 05:47 CEST (Europe/Vienna)

There are no dangerous thoughts;
thinking itself is dangerous.    Hannah Arendt

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5